Gliatech other research news

Gliatech said it has identified prototype proteoglycan and glial cell inhibitors that may slow the progression of Alzheimer's disease.

The Cleveland company presented research showing the role of proteoglycans, molecules with a protein core and sugar side chains made by brain cells, in processing beta amyloid peptide (Aß). ...